Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

FIZ Karlsruhe now markets in-house version of USGENE®, the USPTO Genetic Sequences Database, in Europe

06.05.2009
Agreement gives FIZ Karlsruhe the mandate to operate as SequenceBase Corporation's marketing agent for USGENE® in-house version / USGENE® data available for customized subscription download / expert customer support

For the purpose of promoting the USGENE® in-house version more effectively in Europe, US-based SequenceBase Corporation and FIZ Karlsruhe have entered into an agreement according to which FIZ Karlsruhe will act as a sales agent on behalf of the SequenceBase Corporation.

In this capacity, FIZ Karlsruhe will sell and market the USGENE® database in-house version to customers and prospective customers of the SequenceBase Corporation in enterprises and institutes throughout Europe. USGENE® is also available via FIZ Karlsruhe's leading online-service STN InternationalSM. Both offerings complement each other, but target different user groups.

Scientists working in drug discovery operations, academia, and life sciences may now benefit from the customized in-house version of SequenceBase Corporation's prestigious USGENE® database. USGENE® is the ground-breaking resource for life-science intellectual property professionals, providing unrivalled searchable access to all available peptide and nucleotide sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO). It is the unparalleled resource in which to perform freedom-to-operate, prior art, validity, infringement and competitive intelligence patent sequence searches within United States gene patent publications.

USGENE® data are available in customized subscription formats to suit various in-house molecular biology patent information needs. The database can be implemented and integrated in other life science products such as Laboratory Information Management Systems (LIMS), Drug Discovery Platforms, Patent Portals, Web Host interfaces and other online information services. USGENE® data can be provided in industry standard or customized data formats to suit particular in-house needs.

According to the customers' needs, the USGENE® database can be purchased by segments of data such as class, art unit, patent assignee, inventor, publication date, or any other desired fields. The entire back file from 1982 to date can be licensed; regular weekly updates are provided to subscribers within 3 days of publication by the United States Patent Office.

An agreement between SequenceBase Corp. and FIZ Karlsruhe with respect to the offering of USGENE® via the online-service STN International has been existing since 2006. The unique combination of prestigious STN® patent sequence databases DGENE (GENESEQTM), PCTGEN, REGISTRYSM and USGENE® gives life-science intellectual property professionals the ability to make business critical decisions with much greater certainty.

"We are pleased with this opportunity to deepen our partnership with SequenceBase Corporation which has already proven successful with our joint offering of USGENE® on STN® ", said Sabine Brünger-Weilandt, President and CEO of FIZ Karlsruhe. "Both partners now desire to further collaborate for the purpose of promoting the USGENE® database more effectively in Europe in order to attract new customer groups." Rainer Stuike-Prill, Vice-President Marketing & Sales at FIZ Karlsruhe stated: "We are convinced that FIZ Karlsruhe's long-standing experience in providing information services and customer support will make this new project a success and fully satisfy our customers' demands for first-class information and excellent service."

"Once again, we are delighted to partner with FIZ Karlsruhe, in this new alliance", commented Martin Goffman, President and CEO of the SequenceBase Corporation. "This agreement will strengthen our position in Europe while at the same time providing exceptional local service to our European subscribers".

For further information, please contact:

Martin Goffman
President and CEO
SequenceBase Corporation
Phone: +1 732 549-5433
E-mail: mgoffman@sequencebase.com
FIZ Karlsruhe
Dr. Rainer Stuike-Prill
Vice-President Marketing & Sales
Hermann-von-Helmholtz-Platz 1,
76344 Eggenstein-Leopoldshafen, Germany
Phone: +49-7247-808-555, Fax +49-7247-808-259
E-mail: helpdesk@fiz-karlsruhe.de
Press contact:
FIZ Karlsruhe, Rüdiger Mack
Phone: +49 7247 808 513, E-mail: ruediger.mack@fiz-karlsruhe.de
About FIZ Karlsruhe and STN InternationalSM
FIZ Karlsruhe is an experienced service partner for information management and knowledge transfer in science and industry. Its activities focus on the development of e-Science solutions and the provision of a worldwide unique collection of databases through its online service STN InternationalSM. STN® - The Scientific & Technical Information Network - is jointly operated by FIZ Karlsruhe (Europe) and Chemical Abstracts Service (CAS), Columbus, Ohio (USA) worldwide and is represented in Japan by The Japan Association for International Chemical Information (JAICI). STN® offers a wide range of indispensable databases in various fields of science and technology, including the most distinguished patent files, as well as excellent tools for search, analysis and post-processing of search results. FIZ Karlsruhe also produces databases and information services and operates scientific portals, mainly in mathematics, computer science, energy and crystallography. Primary literature can be ordered through the full-text broker service FIZ AutoDoc. FIZ Karlsruhe is a member of the Leibniz Association (WGL), an association of non-academic scientific research and service institutions.
About the SequenceBase Corporation
The SequenceBase Corporation (www.sequencebase.com) is a leader in providing biosequence information to the legal, biotech, pharmaceutical, scientific, technical, and academic community. USGENE® is our unparalleled resource for freedom-to-operate, prior-art, validity and infringement patent sequence searches, competitive analysis of organizations with gene patent publications, and current awareness alerts (SDIs) from the very latest USPTO sequence data. In addition to being the producer of USGENE® on STN®, SequenceBase provides customized subscription download services of USGENE® data to a wide variety of clients, in multiple standard formats to suit their in-house patent bioinformatics information needs.

To learn more about SequenceBase products and services, email us at mgoffman@sequencebase.com.

Rüdiger Mack | idw
Further information:
http://www.fiz.karlsruhe.de
http://www.sequencebase.com

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

Shape matters when light meets atom

05.12.2016 | Physics and Astronomy

Researchers uncover protein-based “cancer signature”

05.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>